Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Nov 3;7(11):e017504.
doi: 10.1136/bmjopen-2017-017504.

Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study

Affiliations
Comparative Study

Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study

Annabel Price et al. BMJ Open. .

Abstract

Objectives: To use routine clinical data to investigate survival in dementia with Lewy bodies (DLB) compared with Alzheimer's dementia (AD). DLB is the second most common dementia subtype after AD, accounting for around 7% of dementia diagnoses in secondary care, though studies suggest that it is underdiagnosed by up to 50%. Most previous studies of DLB have been based on select research cohorts, so little is known about the outcome of the disease in routine healthcare settings.

Setting: Cambridgeshire & Peterborough NHS Foundation Trust, a mental health trust providing secondary mental health care in England.

Sample: 251 DLB and 222 AD identified from an anonymised database derived from electronic clinical case records across an 8-year period (2005-2012), with mortality data updated to May 2015.

Results: Raw (uncorrected) median survival was 3.72 years for DLB (95% CI 3.33 to 4.14) and 6.95 years for AD (95% CI 5.78 to 8.12). Controlling for age at diagnosis, comorbidity and antipsychotic prescribing the model predicted median survival for DLB was 3.3 years (95% CI 2.88 to 3.83) for males and 4.0 years (95% CI 3.55 to 5.00) for females, while median survival for AD was 6.7 years (95% CI 5.27 to 8.51) for males and 7.0 years (95% CI 5.92 to 8.73) for females.

Conclusion: Survival from first presentation with cognitive impairment was markedly shorter in DLB compared with AD, independent of age, sex, physical comorbidity or antipsychotic prescribing. This finding, in one of the largest clinical cohorts of DLB cases assembled to date, adds to existing evidence for poorer survival for DLB versus AD. There is an urgent need for further research to understand possible mechanisms accounting for this finding.

Keywords: dementia; health informatics; old age psychiatry.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Survival in dementia with Lewy bodies (DLB) versus Alzheimer’s dementia (AlzD). Bands indicate 95% CIs for the cumulative hazard. F, female; M, male.

References

    1. Vann Jones SA, O’Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 2014;44:673–83. 10.1017/S0033291713000494 - DOI - PubMed
    1. Palmqvist S, Hansson O, Minthon L, et al. . Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer’s disease with common cognitive tests. Int J Geriatr Psychiatry 2009;24:1405–12. 10.1002/gps.2277 - DOI - PubMed
    1. Williams MM, Xiong C, Morris JC, et al. . Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 2006;67:1935–41. 10.1212/01.wnl.0000247041.63081.98 - DOI - PubMed
    1. Boström F, Jönsson L, Minthon L, et al. . Patients with Lewy body dementia use more resources than those with Alzheimer’s disease. Int J Geriatr Psychiatry 2007;22:713–9. 10.1002/gps.1738 - DOI - PubMed
    1. Boström F, Jönsson L, Minthon L, et al. . Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2007;21:150–4. 10.1097/WAD.0b013e318065c4a9 - DOI - PubMed

Publication types